Underestimating This Stock Could Be Wall Street's Biggest Mistake in 2024
People can and should consider what Wall Street analysts say about a stock. After all, these analysts are the professionals of the investing world and are compensated very well for their research and opinions.
But that doesn't mean that they're always right. In fact, it looks like they may have made a jaw-dropping mistake with Hims & Hers Health (NYSE: HIMS), an up-and-coming telehealth company that doesn't have the mainstream attention bigger companies have.
The evidence overwhelmingly points to the company making a massive leap in 2024; analysts don't seem to realize it yet. Here is why this glaring error could be your investment opportunity for 2024.
Source Fool.com
